Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate

Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate GlobeNewswire November 14, 2025 Windtree has a total of 59 issued or allowed patents and 17 pending patents for Istaroxime and its SERCA2a activators Windtree received recent notification of allowed Istaroxime patents for acute heart failure in Canada and Mexico […]

Reading International Reports Third Quarter 2025 Results

Reading International Reports Third Quarter 2025 Results GlobeNewswire November 14, 2025 Earnings Call Webcast to Discuss Third Quarter Financial Results Scheduled to Post to Corporate Website on Tuesday, November 18, 2025 NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) — Reading International, Inc. (NASDAQ: RDI) (“Reading” or our “Company”), an internationally diversified cinema and real estate

Boston Hemp Inc. Issues Statement Calling for Full Protection of Legal Hemp Under the 2018 Farm Bill Framework

Boston Hemp Inc. Issues Statement Calling for Full Protection of Legal Hemp Under the 2018 Farm Bill Framework GlobeNewswire November 14, 2025 BOSTON, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) — via IBN – Boston Hemp Inc. today released a formal statement urging federal policymakers to uphold the existing definition and legal status of hemp under

Springbig Reports Third Quarter 2025 Results – Achieves Profitability, Extends Streak of Positive Adjusted EBITDA*

Springbig Reports Third Quarter 2025 Results – Achieves Profitability, Extends Streak of Positive Adjusted EBITDA* GlobeNewswire November 14, 2025 Returned to Profitability with Net Income of $0.2M Third Consecutive Quarter of Positive Adjusted EBITDA Revenue Rises to $5.9M, with AI Integration and Cost Controls Driving Efficiency BOCA RATON, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) —

Everything Blockchain Expands Into the Multi-Billion Dollar iGaming Industry With XR Casino Partnership

Everything Blockchain Expands Into the Multi-Billion Dollar iGaming Industry With XR Casino Partnership GlobeNewswire November 14, 2025 Jacksonville, FL, Nov. 14, 2025 (GLOBE NEWSWIRE) — Everything Blockchain Inc. (OTC: EBZT) announces today that the Company has launched a new suite of blockchain solutions for the rapidly expanding iGaming industry and has begun its first revenue-generating

CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm

CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm GlobeNewswire November 14, 2025 LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national litigation firm, announces that it is investigating claims on behalf of policyholders of Aetna

Chaince Digital Holdings Inc. Chief Strategy Officer Wilfred Daye Shares Vision for Tokenized Finance at TCFA 2025 Annual Conference

Chaince Digital Holdings Inc. Chief Strategy Officer Wilfred Daye Shares Vision for Tokenized Finance at TCFA 2025 Annual Conference GlobeNewswire November 14, 2025 New York, NY, Nov. 14, 2025 (GLOBE NEWSWIRE) — Chaince Digital Holdings Inc. (“Chaince Digital” or the “Company”) (NASDAQ: CD) (formerly Mercurity Fintech Holding Inc.), a leading provider of tokenization solutions and

Primary Packaging Labels Market Size, Trends, Segments, Share and Companies 2025-35

Primary Packaging Labels Market Size, Trends, Segments, Share and Companies 2025-35 According to researchers from Towards Packaging, the global primary packaging labels market, estimated at USD 10.38 billion in 2025, is forecast to expand to USD 18.82 billion by 2034, growing at a CAGR of 6.83% over the forecast period. GlobeNewswire November 14, 2025 Ottawa,

GT Biopharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GT Biopharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 14, 2025 Phase 1 trial evaluating GTB-3650 TriKE(R) for relapsed or refractory (r/r) CD33 expressing hematologic malignancies continues to actively enroll with the next update anticipated in Q1 2026 GTB-5550 TriKE(R) IND submission for B7H3-expressing solid tumors expected in late December

Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates

Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates GlobeNewswire November 14, 2025 Received FDA Fast Track designation for stenoparib in advanced ovarian cancer Reported landmark median overall survival now exceeding 25 months in ongoing Phase 2 trial Advanced DRP(R) platform through new licensing agreement TARPON SPRINGS, Fla., November 14, 2025 –

Scroll to Top